BiotechTube
Home/Incannex Healthcare/Mark Bleackley
MB

Mark Bleackley

Chief Scientific Officer

Incannex Healthcare

Therapeutic Areas

Sleep DisordersPsychiatryInflammatory Diseases

Incannex Healthcare Pipeline

DrugIndicationPhase
IHL-42XObstructive Sleep Apnea (OSA)Phase 2/3
Psi-GADGeneralized Anxiety Disorder (GAD)Phase 2
IHL-675AInflammatory Lung Conditions (e.g., ARDS, COPD)Preclinical / Phase 1

Leadership Team at Incannex Healthcare

JL
Joel Latham
Managing Director and CEO
SB
Stephen Bond
Chief Financial Officer
View full Incannex Healthcare profile